Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) today announced its unaudited financial results for the quarter ended June 30, 2007. * Q1 FY08 Revenue at Rs 12.0 billion ($296 mn) as against Rs 14.0 billion ($346 mn) in Q1 FY07 * Q1 FY08 PAT at Rs 1,825 million ($45 mn) as against Rs 1,398 million ($34 mn) in Q1 FY07 * Growth in revenues at 10% excluding for the upsides from authorized generics